Automated Arthritis Detection Using Artificial Intelligence on Smartphone Photographs (AISynovitis)

December 19, 2024 updated by: Med2Measure

Automated Detection Methods for Inflammatory Arthritis and Formation of an Image Database

The investigators are testing the ability of convolutional neural networks (CNNs), that is artificial intelligence, on smartphone photographs in detecting inflammatory arthritis. This promises to be an efficient, accurate, and non-invasive diagnostic tool that will significantly improve early detection and management of inflammatory arthritis.

Study Overview

Detailed Description

Over the past 4 years the investigators have aimed to help the early detection of arthritis leveraging artificial intelligence. This project aims to detect arthritis based on smart phone photographs of joint areas that make it scalable and available in the community. This group first developed a compelling proof-of-concept pipeline and models using 100 patients. (published in Frontiers in Medicine, Nov 2023, wherein they demonstrated that this technology works with reasonable accuracy in the lab, viz Technology Readiness Level currently stands at 3-4). They followed with a newer paper (submitted for publication, available on preprint server MedRxiv) that trained two different CNNs, a screening CNN on uncropped hands that distinguishes patients from controls followed by joint specific detections.

The system involves supporting infrastructure that will enable efficient detection of arthritis. This includes

  1. Collection of photos in a standardized manner using custom designed boxes
  2. Using and testing a browser pipeline
  3. The CNN models will be trained on the dataset of photographs taken in this and results will be deployed to doctors in the community. This ensures a doctor in the loop that can later take action on the results for further confirmatory tests or management.
  4. Understanding knowledge, attitude of patients and doctors towards AI in clinical decision making algorithms

This is a Prospective, non-interventional study and this project only involves an investigator taking a smartphone photograph of some joint areas kept in standardized positions. This involves no risk to the patient.

Study Type

Observational

Enrollment (Estimated)

3000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Pune, India, 411001
        • Poona Superspeciality Clinic
    • Maharashtra
      • Pune, Maharashtra, India, 411004
        • Rheumatology Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

All patients with inflammatory arthritis. This can include but is not limited to rheumatoid arthritis, lupus, psoriatic arthritis, peripheral spondyloarthritis, viral arthritis.

Description

Inclusion Criteria:

  • Inflammatory arthritis of any etiology

Exclusion Criteria:

  • Severe deformity that hampers standardization of photographs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Inflammatory arthritis
Patients with inflammatory arthritis regardless of etiology including rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosis and viral arthritis
Patients will examination and clinical photographs for convolutional networks to diagnose inflammatory arthritis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Accuracy of AI diagnosis against specialist (rheumatologist) opinion
Time Frame: 3 years
Concordance of detection of synovitis by convolutional neural network (binary) with a clinically diagnosed specialist opinion (rheumatologist opinion)
3 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Accuracy of AI diagnosis against imaging diagnosis on Ultrasound
Time Frame: 3 years
Concordance of detection of synovitis by convolutional neural network (binary) compared to musculoskeletal ultrasound
3 years
Sensitivity to change
Time Frame: 3 years
Can the convolutional neural network detect change from an inflamed to an non-inflamed joint
3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Sanat Phatak, MD, DM, Med2Measure

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 15, 2024

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Study Registration Dates

First Submitted

November 28, 2024

First Submitted That Met QC Criteria

November 28, 2024

First Posted (Actual)

December 4, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 19, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Deidentified photographs and clinical information excluding HIPAA variables

IPD Sharing Time Frame

January 2027-January 2028

IPD Sharing Access Criteria

Researchers with a scientific plan can get in touch with the principal investigator with a brief note.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inflammatory Arthritis

Clinical Trials on AI assisted smartphone diagnosis

Subscribe